Ipamorelin and CJC-1295: Understanding the Research Peptide Combination
Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and the compounds discussed are not approved for human or veterinary use.
What is the Ipamorelin and CJC-1295 combination?
Ipamorelin and CJC-1295 are two research peptides from the growth-hormone secretagogue category. Ipamorelin is a selective ghrelin-receptor (GHSR) agonist, while CJC-1295 is a growth-hormone-releasing-hormone (GHRH) analogue. Because they act on two different receptor systems in laboratory models, they are frequently studied as a pair.
Why these two are studied together
The scientific rationale in the literature is that the two peptides engage complementary signalling pathways of the growth-hormone axis.
- Ipamorelin: a selective GHSR agonist studied for its pulse-like effect on growth-hormone signalling in preclinical models.
- CJC-1295: a GHRH analogue with an extended half-life studied for its effect on the same axis through a different receptor.
Why the “research use only” label matters
Neither peptide is approved as a medicinal product for human use, and growth-hormone secretagogues are prohibited in competitive sport. Research-grade material is intended strictly for laboratory and scientific work and is not for human or veterinary consumption.
Handling and storage
These peptides are generally supplied lyophilised and kept cool, dry and away from light, with reconstituted solution refrigerated and used within the indicated stability window. Follow the documentation supplied with the product.
Frequently asked questions
Why are Ipamorelin and CJC-1295 combined?
They act on two different receptors of the growth-hormone axis (GHSR and GHRH), so they are studied together to examine complementary signalling in laboratory models.
Is the combination approved for human use?
No. It is a research material only and is not intended for human or veterinary use.
Key takeaways
Ipamorelin and CJC-1295 are studied together because they engage two distinct receptor pathways of the growth-hormone axis. The combination is a research material only. Review the Ipamorelin / CJC-1295 mix or the standalone Ipamorelin research product.
References
Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.
Research-grade compounds, verified purity
Every batch ships with a Certificate of Analysis. Explore the full PureChems catalog.